Analyzing the impact of hospital volume on esophageal cancer outcomes
Volume Outcome Relationships and Effects of Adjuvant and Neoadjuvant Therapy in Mortality in Esophageal Cancer
This study looks at whether patients with esophageal cancer do better when treated at hospitals that perform more surgeries for this condition compared to those that do fewer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Richardson, Texas) |
| Trial ID | NCT06343597 on ClinicalTrials.gov |
What this trial studies
This observational study conducts a retrospective analysis to evaluate whether patients with esophageal cancer experience different outcomes based on the volume of surgeries performed at their treating hospital. It compares high-volume facilities, which perform more than five esophagectomies per year, to low-volume facilities, which perform fewer than five. The study aims to clarify the relationship between hospital surgical volume and patient outcomes, including the effectiveness of neoadjuvant and adjuvant therapies. By understanding these dynamics, the research seeks to inform treatment assessments for esophageal cancer patients.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with esophageal cancer.
Not a fit: Patients without a diagnosis of esophageal cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify optimal treatment settings for esophageal cancer, potentially improving patient outcomes.
How similar studies have performed: Previous studies have shown success in understanding volume-outcome relationships in other cancers, such as pancreatic cancer, suggesting potential relevance for esophageal cancer.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * esophageal cancer Exclusion Criteria: * No esophageal cancer
Where this trial is running
Richardson, Texas
- Methodist Richardson Medical Center — Richardson, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Dhiresh Jeyarajah, MD — Methodist Health System
- Study coordinator: Crystee Cooper, DHEd
- Email: clinicalresearch@mhd.com
- Phone: 214-947-1280
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.